These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 505308)

  • 1. [Aspects of hormonal therapy of climacteric cardiopathy associated with ischemic heart disease].
    Kretova NE; Smirnova AA
    Ter Arkh; 1979; 51(8):73-7. PubMed ID: 505308
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of ethynodiol diacetate, 1 mg, plus ethinyl estradiol, 35 micrograms. A phase IV trial. Introduction.
    Friedman AJ
    J Reprod Med; 1991 Apr; 36(4 Suppl):323-4. PubMed ID: 2046079
    [No Abstract]   [Full Text] [Related]  

  • 3. Further investigations concerning bisecurin, a peroral contraceptive of low hormonal contents.
    Bencsik A
    Ther Hung; 1973; 21(2):79-81. PubMed ID: 4792882
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a new estrogen-progestational combination at low doses in gynecologic therapy].
    Seassaro E
    Quad Clin Ostet Ginecol; 1969 Jun; 24(6):385-97. PubMed ID: 5398761
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
    Cremer P; Vekemans M
    Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experiences with the long-term use of the oral low-dosage contraceptive Bisecurin].
    Marjanović M; Berić BM
    Med Pregl; 1975; 28(9-10):425-7. PubMed ID: 1186615
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
    Dickerson V
    J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
    Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
    Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological activities of 3 different types of ethynodiol diacetate-ethynyl estradiol combinations (author's transl)].
    Higashiyama S
    Nihon Funin Gakkai Zasshi; 1978 Oct; 23(4):414-20. PubMed ID: 710724
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys.
    Clarkson TB; Shively CA; Morgan TM; Koritnik DR; Adams MR; Kaplan JR
    Obstet Gynecol; 1990 Feb; 75(2):217-22. PubMed ID: 2300348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial.
    Friedman AJ; Wheeler J
    J Reprod Med; 1991 Apr; 36(4 Suppl):328-33. PubMed ID: 2046081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of progestins. Focus on the novel progestin drospirenone.
    Thorneycroft IH
    J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid contraceptives].
    Matsumoto S
    Horumon To Rinsho; 1972 Jun; 20(6):463-8. PubMed ID: 4673193
    [No Abstract]   [Full Text] [Related]  

  • 17. [The search for new ways with low dose contraceptives. II].
    Tóth F; Gimes R; Horn B; Kerényi T
    Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood serum iron concentration in women using contraceptive agent Angravid-Polfa].
    Mierzwiński R; Małysiak M; Swiatkowski K; Fronczek Z; Chmara J
    Ginekol Pol; 1981 Aug; 52(8):747-50. PubMed ID: 7308820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistaxis secondary to oral contraceptive.
    Man A; Segal S
    Acta Otolaryngol; 1981; 92(3-4):383-4. PubMed ID: 7324906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.